Research Advances

Blog Post

Brain-Computer Interface Technology Could Improve Life for Millions

By Larry Luxner | May 9, 2022

FDA Approves Alexion’s Ultomiris for Treatment of gMG

By Sujatha Gurunathan | April 28, 2022
Blog Post

Researchers Announce Results from a Phase 3 Study of Corticosteroid Dosing to Treat DMD

By Sujatha Gurunathan | April 7, 2022
Blog Post

Simply Stated: What is Becker Muscular Dystrophy?

By Sujatha Gurunathan | January 6, 2022
Blog Post

FDA Approves argenx’s Vyvgart for Treatment of gMG

By Sujatha Gurunathan | December 20, 2021
Blog Post

Capricor Announces Positive Results from its Phase 2 Study of CAP-1002 to Treat DMD

By Sujatha Gurunathan | September 30, 2021
Featured Article

One in a Million

By Debra Gordon | August 20, 2021
Featured Article

Researchers Want to Know More About Oculopharyngeal Muscular Dystrophy

By MDA Staff | August 20, 2021
Blog Post

FDA Approves Sanofi Genzyme’s Nexviazyme for Treatment of Pompe Disease

By MDA Staff | August 6, 2021
Blog Post

FDA approves Octapharma’s Octagam® 10% for Treatment of Adults with Dermatomyositis

By Sujatha Gurunathan | July 29, 2021